Abbott Laboratories (ABT): return on equity, 10 filed years
ROE at Abbott Laboratories was 12.5% in FY2025, the newest filed year. Across the 10 computed years from FY2016 it ranged from 1.5% (FY2017) to 28.1% (FY2024), with a median of 13.1%.
Tonight's figure on the company page: 12.5%, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | ROE | Read from |
|---|---|---|
| FY2016 | 6.8% | 10-K, filed 2017-02-17 |
| FY2017 | 1.5% | 10-K, filed 2018-02-16 |
| FY2018 | 7.8% | 10-K, filed 2019-02-22 |
| FY2019 | 11.9% | 10-K, filed 2020-02-21 |
| FY2020 | 13.7% | 10-K, filed 2021-02-19 |
| FY2021 | 19.8% | 10-K, filed 2022-02-18 |
| FY2022 | 18.9% | 10-K, filed 2023-02-17 |
| FY2023 | 14.8% | 10-K, filed 2024-02-16 |
| FY2024 | 28.1% | 10-K, filed 2025-02-21 |
| FY2025 | 12.5% | 10-K, filed 2026-02-20 |
How each year is computed
Net income / shareholders equity x 100
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.